Example: Heart Attack

Search clinical trials for: Gastrointestinal Agents

Total 9260 results

NCT01696656

Completed

Prescription Pattern of Adjuvant Drugs and Vitamins in Patients Undergoing Long-term Home Nutritional Support for Intestinal Insufficiency

Conditions: Intestinal Insufficiency; Short Bowel Syndrome
NCT00905242

Completed

Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients

Conditions: Kidney Transplantation
NCT01650870

Completed

Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults

Conditions: Colonoscopy
NCT03885310

Recruiting

INGEST I Pilot Study

Conditions: Esophageal Stricture
NCT04576208

Not yet recruiting

A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788

Conditions: Non-Small Cell Lung Cancer (NSCLC)
NCT02936375

Recruiting

The Iguratimod Effect on Lupus Nephritis (IGeLU)

Conditions: Lupus Nephritis
NCT01704651

Completed

Accelerating Gastrointestinal Recovery

Conditions: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
NCT02674308

Active, not recruiting

Entyvio (Vedolizumab) Long Term Safety Study

Conditions: Ulcerative Colitis and Crohn's Disease
NCT02678052

Recruiting

OTIS Vedolizumab Pregnancy Exposure Registry

Conditions: Colitis, Ulcerative; Crohn's Disease
NCT04002180

Recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

Conditions: Crohn's Disease
NCT03824561

Recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

Conditions: Ulcerative Colitis
NCT03352414

Terminated

Trial Investigating Alvimopan for Enhanced Gastrointestinal Recovery After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Conditions: Ileus
NCT03924947

Recruiting

A Study to Compare US Marketed Pancrelipase Drug Product With Drug Product Manufactured With a Modernized Process at an Alternate Manufacturing Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis.

Conditions: Cystic Fibrosis
NCT02165475

Completed

Combination Therapy With Biofeedback, Loperamide and Stool Bulking Agents

Conditions: Fecal Incontinence
NCT04006080

Recruiting

Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis

Conditions: Ulcerative Colitis
NCT04315116

Not yet recruiting

A Drug-drug Interaction Trial of Loperamide Pharmacokinetics Effect on Pyrotinib Maleate

Conditions: Healthy Participants
NCT03705442

Unknown status

Probiotics as Adjuvant Therapy in the Treatment of Metastatic Colorectal Cancer

Conditions: Colorectal Cancer Metastatic
NCT02379858

Terminated

Gastrointestinal Tract Recovery in Patients Undergoing Open Ventral Hernia Repair

Conditions: Ventral Hernia
NCT03177434

Unknown status

Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years.

Conditions: Constipation
NCT02402439

Active, not recruiting

Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol

Conditions: Diabetes Mellitus, Type 1
NCT03961308

Completed

A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants

Conditions: Healthy Volunteers
NCT03961295

Completed

A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants

Conditions: Healthy Volunteers
NCT03949621

Completed

A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants

Conditions: Healthy Volunteers
NCT03948581

Completed

A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants

Conditions: Healthy Volunteers
NCT04362735

Not yet recruiting

Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy

Conditions: Crohn Disease